Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gastrointestinal Stromal Tumors × pemigatinib × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 1 Cholangiocarcinoma 1

Interventions

Specimen Handling 2 Magnetic Resonance Spectroscopy 2 trastuzumab deruxtecan 1 ripretinib 1 pemigatinib 1 Sunitinib 1 Rogaratinib 1 Nivolumab 1 Ipilimumab 1 Imatinib Mesylate 1 Cyclophosphamide 1 CTLA-4 Antigen 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07434843 2026-02-27

PEMIGIST

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡